139 related articles for article (PubMed ID: 25680401)
1. Correlation between (68)Ga-DOTA-NOC PET/CT and (18)F-FDG PET/CT in EBV-positive undifferentiated nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1162-3. PubMed ID: 25680401
[No Abstract] [Full Text] [Related]
2. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Naswa N; Sharma P; Suman Kc S; Lata S; Kumar R; Malhotra A; Bal C
Nucl Med Commun; 2012 Jul; 33(7):766-74. PubMed ID: 22531829
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal tuberculosis mimicking nasopharyngeal carcinoma on (18)F-FDG PET/CT in a young patient.
Zhang Y; Chen Y; Huang Z; Cai L; Wu J
Clin Nucl Med; 2015 Jun; 40(6):518-20. PubMed ID: 25546210
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in the management of nasopharyngeal carcinoma.
Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
[TBL] [Abstract][Full Text] [Related]
7. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
[TBL] [Abstract][Full Text] [Related]
8. (68)Ga-DOTA (0)-Tyr (3)-octreotide positron emission tomography in nasopharyngeal carcinoma.
Schartinger VH; Dudás J; Url C; Reinold S; Virgolini IJ; Kroiss A; Riechelmann H; Uprimny C
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):20-4. PubMed ID: 25227762
[TBL] [Abstract][Full Text] [Related]
9. Whole-body
Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
[TBL] [Abstract][Full Text] [Related]
10. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
[TBL] [Abstract][Full Text] [Related]
11. Lower neck neurilemmoma can masquerade as lymph node metastasis on FDG PET/CT in patient with nasopharyngeal carcinoma.
Hsieh TC; Wu YC; Hsu CN; Yang CF; Yen KY; Kao CH; Sun SS
Clin Nucl Med; 2011 Dec; 36(12):e217-9. PubMed ID: 22064115
[No Abstract] [Full Text] [Related]
12. Tumor heterogeneity measured on F-18 fluorodeoxyglucose positron emission tomography/computed tomography combined with plasma Epstein-Barr Virus load predicts prognosis in patients with primary nasopharyngeal carcinoma.
Chan SC; Chang KP; Fang YD; Tsang NM; Ng SH; Hsu CL; Liao CT; Yen TC
Laryngoscope; 2017 Jan; 127(1):E22-E28. PubMed ID: 27435352
[TBL] [Abstract][Full Text] [Related]
13. Circulating EBV DNA and ¹⁸F-FDG PET scan in the diagnosis and monitoring of nasopharyngeal carcinoma.
Wang WY; Lin PJ; Lin JC
J Formos Med Assoc; 2012 Feb; 111(2):118-9. PubMed ID: 22370292
[No Abstract] [Full Text] [Related]
14. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of standardized uptake value of F-18 FDG PET/CT in nasopharyngeal carcinoma.
Chan WK; Kwong DL; Yeung DW; Huang B; Khong PL
Clin Nucl Med; 2011 Nov; 36(11):1007-11. PubMed ID: 21975389
[TBL] [Abstract][Full Text] [Related]
17. Rare case of gall bladder neuroendocrine tumor: ¹⁸F-FDG and ⁶⁸Ga-DOTANOC PET/CT findings.
Chakraborty PS; Dhull VS; Karunanithi S; Roy SG; Kumar R
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):316-7. PubMed ID: 25043774
[No Abstract] [Full Text] [Related]
18. A low F-18 FDG uptake in the nasopharynx plasmacytoma detected by FDG PET/CT.
Dong MJ; Liu ZF; Wang GL; Zhao K; Sun ML; Wang HT; Yang SY
Clin Nucl Med; 2011 Nov; 36(11):1053-5. PubMed ID: 21975405
[No Abstract] [Full Text] [Related]
19. Updates on MR imaging and ¹⁸F-FDG PET/CT imaging in nasopharyngeal carcinoma.
Lai V; Khong PL
Oral Oncol; 2014 Jun; 50(6):539-48. PubMed ID: 23769923
[TBL] [Abstract][Full Text] [Related]
20. A new brain positron emission tomography scanner with semiconductor detectors for target volume delineation and radiotherapy treatment planning in patients with nasopharyngeal carcinoma.
Katoh N; Yasuda K; Shiga T; Hasegawa M; Onimaru R; Shimizu S; Bengua G; Ishikawa M; Tamaki N; Shirato H
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e671-6. PubMed ID: 22245187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
